N‐RAS activation is ubiquitous in AML cells, so the dual effects of wogonoside on PLSCR1 and N‐RAS have extend the scope of effect of wogonoside on various types of AML to a certain extent. This evidence concerns the gene NRAS and acute myeloid leukemia.